NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 171 filers reported holding NXSTAGE MEDICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $791,000 | -51.3% | 30,173 | -53.5% | 0.00% | -50.0% |
| Q3 2016 | $1,623,000 | +22.1% | 64,927 | +5.9% | 0.00% | 0.0% |
| Q2 2016 | $1,329,000 | +72.4% | 61,284 | +4.7% | 0.00% | +100.0% |
| Q3 2013 | $771,000 | -1.4% | 58,553 | +7.0% | 0.00% | 0.0% |
| Q2 2013 | $782,000 | – | 54,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |